中通快遞-SW(02057.HK)發售8.7億美元可換股優先票據
格隆匯8月25日丨中通快遞-SW(02057.HK)今日宣佈本金額合共8.70億美元的2027年到期的可換股優先票據的定價。票據已向獲合理相信屬合資格機構買家的人士提呈發售。此外,公司已向票據發售事項獲的初始買方授出期權,可於票據發售事項日期(包括該日)起計13天內行使結算,以增購本金總額最多1.30億美元的票據。
票據將按每年1.50%的利率計息,於2023年3月1日起計,須於每年的3月1日及9月1日每半年支付一次。票據將於2027年9月1日到期,除非在該日之前按其條款提早贖回、購回或轉換。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.